Acute Complications and Survival Analysis of Childhood Acute Lymphoblastic Leukemia: A 15-year Experience
- PMID: 33046422
- DOI: 10.1016/j.clml.2020.08.025
Acute Complications and Survival Analysis of Childhood Acute Lymphoblastic Leukemia: A 15-year Experience
Abstract
Background: We evaluated the acute complications that occurred during the treatment of childhood acute lymphoblastic leukemia (ALL) and documented the survival rates of children with ALL.
Materials and methods: We retrospectively evaluated 110 children with a diagnosis of ALL treated with the Children's Oncology Group protocol from 1999 to 2014. The demographic, clinical, and laboratory data of 110 patients and acute complications of eligible and evaluable 105 patients were recorded.
Results: Of the 110 patients, 65 were male and 45 were female. The mean age at admission was 8.3 ± 5.2 years. Ninety-seven patients (88.2%) had been diagnosed with pre-B-cell ALL, 11 (10%) with T-cell ALL, 1 (0.9%) with mixed phenotype acute leukemia, and 1 (0.9%) with mature B-cell acute leukemia. Of the 110 patients, 40 (36.3%) were in the standard-risk group and 70 (63.7%) were in high-risk group. Of the 110 patients, 105 had been followed up regularly and evaluated for acute complications. Infection was the most common complication (n = 93; 88.5%), followed by gastrointestinal (n = 29; 27.6%), neurologic (n = 28; 26.6%), metabolic/endocrine (n = 16; 15.2%), drug-related hypersensitivity (n = 16; 15.2%), avascular necrosis (n = 13; 12.3%), thrombotic (n = 11; 10.4%), severe psychiatric (n = 2; 1.9%), and various other (n = 12; 11.4%) complications. Of the 110 patients, 98 were assessed in terms of survival analysis. The 5- and 10-year overall survival rates were both 85.9% (standard error [SE], 3.6%). The relapse-free survival rates at 1, 3, and 5 years were 97.9% (SE, 1.5%), 91.3% (SE, 3%), and 86.3% (SE, 3.7%), respectively.
Conclusion: Childhood ALL, although categorized as curable malignancy owing to the improvements in treatment strategies in recent years, can cause acute complications affecting various systems. Thus, patients should be treated and followed up by multidisciplinary medical teams with high expertise.
Keywords: Acute leukemia; Childhood; Complications; Relapse; Survival.
Copyright © 2020 Elsevier Inc. All rights reserved.
Similar articles
-
[Long-term outcome of childhood T-cell acute lymphoblastic leukemia treated with modified national protocol of childhood leukemia in China-acute lymphoblastic leukemia 2008].Zhonghua Er Ke Za Zhi. 2020 Sep 2;58(9):758-763. doi: 10.3760/cma.j.cn12140-20200116-00035. Zhonghua Er Ke Za Zhi. 2020. PMID: 32872717 Chinese.
-
Long-Term Outcomes of Modified St Jude Children's Research Hospital Total Therapy XIIIB and XV Protocols for Thai Children With Acute Lymphoblastic Leukemia.Clin Lymphoma Myeloma Leuk. 2019 Aug;19(8):497-505. doi: 10.1016/j.clml.2019.04.006. Epub 2019 Apr 19. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31103474
-
Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse--the Children's Cancer Group Experience.Cancer. 1998 Apr 1;82(7):1387-95. doi: 10.1002/(sici)1097-0142(19980401)82:7<1387::aid-cncr24>3.0.co;2-1. Cancer. 1998. PMID: 9529033
-
Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.J Pediatr Hematol Oncol. 2001 Dec;23(9):591-7. doi: 10.1097/00043426-200112000-00008. J Pediatr Hematol Oncol. 2001. PMID: 11902303 Review.
-
[Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].Beijing Da Xue Xue Bao Yi Xue Ban. 2013 Apr 18;45(2):327-32. Beijing Da Xue Xue Bao Yi Xue Ban. 2013. PMID: 23591360 Review. Chinese.
Cited by
-
Treatment of Invasive Fungal Disease During Therapy for Acute Lymphoblastic Leukemia.J Med Cases. 2025 May;16(5):174-180. doi: 10.14740/jmc5066. Epub 2025 May 28. J Med Cases. 2025. PMID: 40503543 Free PMC article.
-
Successful VA ECMO on an adolescent pre-B cell acute lymphoblastic leukemia patient with necrotizing fasciitis from Clostridium septicum.Arch Clin Cases. 2025 Aug 20;12(3):119-122. doi: 10.22551/2025.48.1203.10323. eCollection 2025. Arch Clin Cases. 2025. PMID: 40843210 Free PMC article.
-
miRNAs in Lymphocytic Leukaemias-The miRror of Drug Resistance.Int J Mol Sci. 2022 Apr 22;23(9):4657. doi: 10.3390/ijms23094657. Int J Mol Sci. 2022. PMID: 35563051 Free PMC article. Review.
-
Impact of race/ethnicity and language preferences on pediatric ALL survival outcomes.Cancer Med. 2023 Jun;12(11):12827-12836. doi: 10.1002/cam4.5951. Epub 2023 Apr 16. Cancer Med. 2023. PMID: 37062075 Free PMC article.
-
Clinical characteristics and risk factors of acute lymphoblastic leukemia in children with severe infection during maintenance treatment.Cancer Med. 2023 Oct;12(19):19372-19382. doi: 10.1002/cam4.6495. Epub 2023 Sep 28. Cancer Med. 2023. PMID: 37768027 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources